Drug Device Combination Products: Delivery Technologies and Applications / Edition 1

Hardcover (Print)
Not Available on BN.com


Drug delivery systems represent a vast area of research and development within biomaterials and medicine and the demand for sophisticated drug delivery devices continues to drive novel product development. This book illustrates how effective drug delivery can be achieved by means other than tablets. Written by an international team of experts, this book provides a thorough analysis of the fundamentals, applications, and new technologies of drug-device combination products for use throughout the human body. Topics featured include background information, areas of application and the development of drug device combination products.

Read More Show Less

Product Details

  • ISBN-13: 9781439824795
  • Publisher: Taylor & Francis
  • Publication date: 2/3/2010
  • Edition number: 1
  • Pages: 542
  • Product dimensions: 0.60 (w) x 0.90 (h) x 1.40 (d)

Meet the Author

Andrew Lewis is Research & Technology Director for Biocompatibles UK Ltd and Visiting Professor of Biomaterials & Drug Delivery at the University of Brighton.

Read More Show Less

Table of Contents


Drug-device combination products
Y Wang and J Burgess, University of Connecticut, USA
Introduction. Rationale for drug device combination applications. Drug enhanced device products. Device-based drug delivery systems. Summary. References.

Enabling drug delivery from combination products
A Lewis, Biocompatibles UK Ltd, UK
Introduction. Which drugs and why? Achieving controlled release from a device. Biologic-device combinations. Concluding remarks. References.

Nanomedical drug device combination products
M Bünger, Lux Research Inc., USA
Introduction. Nanomedical combination products (NMCPs). Benefits of nanomedical combination products. Future trends: exploring new principles for designing combination products. References.


Catheter-based drug device combination products: an overview
B Gilmore, T Hamill, S Gorman and D Jones, Queen’s University Belfast, UK
Introduction. Current materials employed in catheter manufacture. Infectious complications associated with the use of indwelling catheters. Complications associated with urological catheters. Complications associated with central venous catheters. Complications associated with peritoneal catheters. Conclusion. References.

Catheter-based drug device combination products: the anti-infective 5-fluorouracil-coated central venous catheter (5-FU CVC)
R Avelar and A Jonker, Angiotech Pharmaceuticals, Inc., Canada
Introduction. Preclinical testing. Clinical Study. Conclusions. References.

Future outlook for drug eluting stents (DES)
K Vedantham, S Chaterji, and J Kitsongsermthon, Purdue University, J Garner, and K Park, Akina Inc, USA
Introduction. Drug eluting stents: Where are we now? Challenges in the use of drug eluting stents. Strategic approaches for future use of drug eluting stents. Summary. Acknowledgements. References.

Drug eluting beads (DEB) in the treatment of liver cancer
A Lewis, Biocompatibles UK Ltd, UK
Introduction. Embolisation therapy. The drug eluting beads (DEB) technology platform. Clinical evaluation of dox drug eluting beads. Interactions of drug eluting beads with irinotecan and comparison with dox. Clinical evaluation of irinotecan drug eluting beads (DEBIRI). Conclusions and future trends. Acknowledgements. References.

Antibiotic-loaded bone cements
D Farrar, R Benson and R Milner, Smith & Nephew Research Centre, UK
Introduction. The need for antibiotics in joint replacement. The development of antibiotic-loaded cements. Choice of antibiotic. Performance characteristics of antibiotic-loaded bone cements. Current products and clinical usage. Regulatory position. Future trends. Conclusions. References.

Glass ionomer cements as drug device combination products
P V Hatton, Sheffield University and G Palmer, UCL Eastman Dental Institute, UK
Introduction. Composition and setting chemistry. Ion release from glass-ionomer cements. Release of antiseptics and related compounds. Conclusions. Acknowledgements. References.

Bone graft substitutes as drug device combination products
G Koller, B Buranawat and L Di Silvio, King’s College London, UK
Introduction. Bone graft substitutes. Bone graft substitutes as combinational drug delivery systems (DDS). Bone substitute combinations with recombinant technology to confer enhanced bioactivity. Future trends of drug delivery systems within the field of bone graft substitution. References.

Anti-bacterial releasing dental restorative materials
A Young, UCL Eastman Dental Institute, UK
Introduction. Dental composites. Glass ionomer cements. Hybrid restorative materials. Resin adhesives. Calcium phosphate-containing resins. Chlorhexidine-containing dental materials. Conclusions and future trends. References.

Collagen-based dressings as therapeutic agents for wound healing
D Silcock, Systagenix Wound Management, UK
Introduction. Biomaterials in wound repair. Collagen-based wound dressings. Collagen composite dressings. Collagen dressings with therapeutic agents. Other therapeutics agents for wound healing. Future trends. References.

Drug device combination products for occular applications
R Willams and V Kearns, University of Liverpool, UK
Introduction. Contact lens. Glaucoma. Cataract and intraocular lens (IOL). Vitreous substitutes. Biological combinational products. Concluding remarks. Sources for further information and advice. References.


Safety and efficacy issues in designing drug device combination products: the case of drug eluting stents (DES)
S Willis and V O’Byrne, Biocompatibles UK Ltd, UK
Introduction. Percutaneous translumal coronary balloon angioplasty. Coronary stenting using bare metal stents (BMS). Combination devices to treat the symptoms of coronary artery disease (CAD). Coronary stenting with drug eluting stents (DES). Acknowledgements. References.

Preclinical testing of drug device combination products
G Clermont, A Alves, X Palazzi and J P Boutrand, Biomatech, a NAMSA Company, France
Introduction. Preclinical safety evaluation of combination products. Preclinical evaluation of performance and bioactivity of combination products. Pathological evaluation of combination products. Conclusion. References.

Sterilisation of drug device combination products
B Parsons, Leeds Metropolitan University, UK
Introduction. Principles of radiation chemistry. Radiation chemistry of aqueous solutions: an overview. Types and yields of water-derived free radicals. Radiation chemistry of components of drug-device products. Sterilisation of proteins and enzymes. Sterilisation of pharmaceutical drugs. Sterilisation of drug delivery systems. Principles of sterilisation of healthcare and related products. Conclusions and future trends. Sources of further information and advice. References.

Innovation and patent issues in the development of drug device combination products: the case of drug eluting stents (DES)
P Baxter, Biocompatibles UK Ltd, UK
Introduction. Drug eluting stent an innovation map. The innovation landscape. Conclusions. References.

Regulation of drug device combination products in Europe
S Leppard, Biocompatibles UK Ltd, UK
Introduction. CE mark jurisdiction. Brief history of medicinal products and medical device legislation. Guidance documents. Mode of action. Device classification. In vitro, in vivo and clinical evaluation of combination products. Submissions for CE approval. Roles of notified bodies vs. competent authorities. Future trends: MDD revisions. Web references.

Regulation of drug device combination products in the US
J Greenbaum, Generic Devices Consulting, Inc., USA
Introduction. What is a combination product? Assignment of designation. Requests for designation. Requests for classification. Drug designations. Device designations. Biologics designations. Investigational device exemption (IDE). Investigational new drug application (IND). 510K pre-market notifications. Pre-market approval applications. New drug applications. Quality system requirements for combination products. Issues at US Food and Drug Administration (FDA) and in industry with the uniqueness presented in combination products. Abbreviations. References.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star


4 Star


3 Star


2 Star


1 Star


Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation


  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)